FDA expands use of RU-486 abortion pill
April 06, 2016
The US Food and Drug Administration has announced that the RU-486 abortion pill may now be used in the first ten weeks following the mother’s last period.
The FDA, which approved the use of RU-486 (also known as Mifeprex and Mifepristone) in 2000, previously permitted its use in the first seven weeks. RU-486 now accounts for over 22% of abortions in the US.
“The FDA has irresponsibly loosened its guidelines for the dangerous abortion drug RU-486, expanding its use an additional three weeks into pregnancy, and allowing provision by non-physicians,” said Cardinal Timothy Dolan, chairman of the United States Conference of Catholic Bishops' Committee on Pro-Life Activities.
“The unofficial, off-label use of RU-486 is now the new normal, paving the way for the destruction of even more innocent lives, and putting women and girls at risk for all the life-changing effects of abortion,” he added. “Far from wanting abortion to be 'rare', abortion advocates are celebrating this expanded use as opening an ever-widening door to abortion.”
For all current news, visit our News home page.
- Questions and Answers on Mifeprex (FDA)
- FDA Allows RU-486 Abortions To Expand (The Federalist)
- RU 486 Abortion Pill Marks 15th Anniversary in the US, Kills 22% of Unborn Babies Every Year (LifeNews.com)
- Cardinal Dolan Calls New FDA Abortion Drug Guidelines 'Irresponsible,' Offers Assistance To Pregnant Women (USCCB)
All comments are moderated. To lighten our editing burden, only current donors are allowed to Sound Off. If you are a donor, log in to see the comment form; otherwise please support our work, and Sound Off!